Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 69

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 69
---
 the average SCT total compensation for our non-PEO NEOs, each as disclosed in the table above, are included in the following graph as supplemental disclosures for each of the periods presented. 43 TABLE OF CONTENTS 44

TABLE OF CONTENTS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth certain information known to us regarding beneficial ownership of our voting securities as of March 21, 2025 by: • each person known by us to be the beneficial owner of more than 5% of any class of our voting securities; • our named executive officers; • each of our directors; and • all executive officers and directors as a group. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Except as noted by footnote, and subject to community property laws where applicable, the persons named in the table below have sole voting and investment power with respect to all ordinary shares shown as beneficially owned by them. The table below is based upon information supplied by officers, directors, Forms 4, and Schedules 13G and 13D filed with the SEC. This table lists applicable percentage ownership based on 50,001,332 ordinary shares outstanding as of March 21, 2025. Options to purchase our ordinary shares that are exercisable within 60 days of March 21, 2025 and RSUs subject to release within 60 days of March 21, 2025 are deemed to be beneficially owned by the persons holding these options and RSUs, as applicable, for the purpose of computing percentage ownership of that person, but are not treated as outstanding for the purpose of computing any other person’s ownership percentage.

| ​                                                                               | ​ | ​ | Beneficial Ownership |   |           |   |   |   |                                            |   |        |   | ​ |
| Name and Address of Beneficial Owner(1)                                         | ​ | ​ | Number of Shares     |   |           |   | ​ | ​ | Percent of TotalOutstanding OrdinaryShares |   |        |   | ​ |
| Greater than 5% Shareholders                                                    | ​ | ​ | ​                    | ​ |         ​ | ​ | ​ | ​ | ​                                          | ​ | ​      | ​ | ​ |
| Madison Avenue Partners, LP﻿(2)150 East 58th Street 14th FloorNew York NY 10155 | ​ | ​ | ​                    |